George Eldridge

George A. Eldridge formerly worked at Alseres Pharmaceuticals, Inc., as Chief Financial Officer & VP-Corporate Development from 1993 to 1996, Curis, Inc., as Chief Financial Officer & Vice President from 1996 to 2002, Proteon Therapeutics, Inc., as CFO, Secretary, Treasurer & Senior VP from 2014 to 2020, Targanta Therapeutics Corp., as CFO, Treasurer, Senior VP-Administration & Finance from 2006 to 2009, Ontogeny, Inc., as Vice President-Finance from 1996 to 2000, Therion Biologics Corp., as Chief Financial Officer & Senior Vice President from 2002 to 2006, Kidder, Peabody & Co., Inc., as Investment Banker, AlloCure, Inc., as Chief Financial Officer, Lyndra Therapeutics, Inc., as Chief Financial Officer & Senior Vice President from 2020 to 2021, Sollis Therapeutics, Inc., as Chief Financial Officer in 2020, Protara Therapeutics, Inc., as Chief Financial Officer, and Jade Biosciences, Inc., as Treasurer, Chief Financial & Compliance Officer from 2021 to 2025.
Mr. Eldridge received his undergraduate degree from Dartmouth College and Masters Business Admin degree from The University of Chicago Booth School of Business.